We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.9B
AUM Growth
+$1.18B
Cap. Flow
-$95.1M
Cap. Flow %
-0.46%
Top 10 Hldgs %
24.18%
Holding
1,443
New
92
Increased
575
Reduced
559
Closed
58

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$49.3M
2
IQV icon
IQVIA
IQV
+$42.7M
3
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$34.7M
4
COR icon
Cencora
COR
+$32.7M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$22.7M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$61.8M
2
PGR icon
Progressive
PGR
+$60.9M
3
ANET icon
Arista Networks
ANET
+$23.1M
4
PATH icon
UiPath
PATH
+$22.5M
5
EBAY icon
eBay
EBAY
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 23.2%
2 Healthcare 11.29%
3 Financials 10.11%
4 Consumer Discretionary 8.76%
5 Industrials 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVY icon
576
Avery Dennison
AVY
$12.8B
$1.88M 0.01%
8,523
+297
+4% +$64.1K
UBER icon
577
Uber
UBER
$145B
$1.87M 0.01%
24,941
+5,684
+30% +$400K
CSW
578
CSW Industrials
CSW
$4.44B
$1.87M 0.01%
5,100
-197
-4% -$61.5K
ED icon
579
Consolidated Edison
ED
$41.4B
$1.86M 0.01%
17,908
+454
+3% +$44.9K
SANM icon
580
Sanmina
SANM
$8.78B
$1.86M 0.01%
27,177
-1,429
-5% -$98.6K
BCPC
581
Balchem Corp
BCPC
$5.26B
$1.86M 0.01%
10,545
-427
-4% -$72.7K
RS icon
582
Reliance Steel & Aluminium
RS
$20.6B
$1.84M 0.01%
6,374
-6,601
-51% -$1.89M
AMPH icon
583
Amphastar Pharmaceuticals
AMPH
$907M
$1.84M 0.01%
37,884
+22,439
+145% +$985K
QRVO icon
584
Qorvo
QRVO
$7.9B
$1.84M 0.01%
17,785
-109,157
-86% -$12.3M
TRP icon
585
TC Energy
TRP
$70.1B
$1.84M 0.01%
38,620
-2,029
-5% -$88.2K
SJM icon
586
J.M. Smucker
SJM
$13.5B
$1.83M 0.01%
15,107
-539
-3% -$63.5K
ROAD icon
587
Construction Partners
ROAD
$5.88B
$1.83M 0.01%
26,155
-5,439
-17% -$335K
FITB
588
Fifth Third Bancorp
FITB
$51.3B
$1.81M 0.01%
42,352
-10,944
-21% -$445K
WCN
589
Waste Connections
WCN
$43.6B
$1.81M 0.01%
10,126
-959
-9% -$174K
VMC icon
590
Vulcan Materials
VMC
$36.8B
$1.8M 0.01%
7,201
-211
-3% -$52.4K
MELI icon
591
Mercado Libre
MELI
$94.5B
$1.8M 0.01%
877
-476
-35% -$896K
VONE icon
592
Vanguard Russell 1000 ETF
VONE
$8.09B
$1.79M 0.01%
6,880
– –
CWAN
593
DELISTED
Clearwater Analytics
CWAN
$1.76M 0.01%
69,828
+39,343
+129% +$885K
ACM icon
594
Aecom
ACM
$9.46B
$1.75M 0.01%
16,994
+4,482
+36% +$421K
EOG icon
595
EOG Resources
EOG
$77.7B
$1.75M 0.01%
14,274
-106
-0.7% -$13.3K
EXPD icon
596
Expeditors International
EXPD
$22.3B
$1.75M 0.01%
13,348
+1,878
+16% +$230K
DLR icon
597
Digital Realty Trust
DLR
$69.6B
$1.73M 0.01%
10,711
+314
+3% +$48.1K
AES icon
598
AES
AES
$10.6B
$1.73M 0.01%
86,387
-1,056
-1% -$18.7K
MTD icon
599
Mettler-Toledo International
MTD
$28.1B
$1.73M 0.01%
1,155
+25
+2% +$35.1K
BSX icon
600
Boston Scientific
BSX
$68.4B
$1.71M 0.01%
20,463
+3,261
+19% +$257K
22 23
24
25 26

Similar funds

EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
SC
Savant Capital Rockford, Illinois $20.7B AUM 19.76% 1-Year Est. Return

Glenmede Trust's Q3 2024 Portfolio in Review

As of Q3 2024, Glenmede Trust held 1,443 positions worth $20.9B, up 6% from $19.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Glenmede Trust's Q3 2024 filing shows 92 new, 575 increased, 559 reduced and 58 closed positions. Its largest new stake was NOV: 859,708 shares worth $13.7M. The largest sale was Vertex Pharmaceuticals, an estimated $61.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's largest Q3 2024 buy was NOV: 859,708 shares worth $13.7M.
  • Glenmede Trust added most to Merck in Q3 2024, an estimated $49.3M increase.
  • Glenmede Trust's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $61.8M.
  • Glenmede Trust fully exited Pacira BioSciences in Q3 2024, selling an estimated $10.5M.
  • Glenmede Trust's ten largest holdings make up 24% of its $20.9B portfolio in Q3 2024.
  • Glenmede Trust opened 92 new positions and closed 58 in Q3 2024.
  • Glenmede Trust's portfolio value rose 6% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q3 2024, filed 13 Nov 2024.